JOUT’s revenue growth was impressive into FY21 (CAGR: 8%), however, the company has seriously struggled subsequently. Demand is softening and economic headwinds are wreaking havoc. We like its ...

Halma continues to maintain its health growth trajectory, comprised of a broadly equal contribution from M&A and organic growth. The company is a leader in a number of segments within its industry, ...

Making quality business decisions is no longer about trusting a hunch or leaning only on past experience. The real challenge for companies today is learning how to make sense of the overwhelming ...